Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysis.
about
Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Results of a phase II study of ...... lymphoma: an interim analysis.
@en
Results of a phase II study of ...... lymphoma: an interim analysis.
@nl
type
label
Results of a phase II study of ...... lymphoma: an interim analysis.
@en
Results of a phase II study of ...... lymphoma: an interim analysis.
@nl
prefLabel
Results of a phase II study of ...... lymphoma: an interim analysis.
@en
Results of a phase II study of ...... lymphoma: an interim analysis.
@nl
P2093
P2860
P1476
Results of a phase II study of ...... lymphoma: an interim analysis.
@en
P2093
Byung-Su Kim
Dok Hyun Yoon
Dong-Yeop Shin
Hyo Jung Kim
Jee Hyun Kong
Jeong-A Kim
Jong-Ho Won
Seok Jin Kim
Sung-Kyu Park
Won Seog Kim
P2860
P2888
P304
P356
10.1007/S00280-016-3005-Y
P577
2016-03-16T00:00:00Z